The LiverWELL Board of Directors is made up of individuals who have the skills and experience to help us achieve the organisation’s vision.
Meet our CEO
A strategic business leader and experienced CEO, Elaine has senior executive leadership and governance experience across diverse sectors and cultures. Elaine has held executive leadership roles in the international development and community sectors including with Oxfam and Australian Red Cross, and is passionate about improving access to basic human rights, especially healthcare, for all communities. She is the Board Chair of GenWest, which supports communities in the west of Melbourne to live safe, healthy lives and advocates for greater gender justice and equity.
Meet our Board
Maria is a partner in a Melbourne law firm and works mainly in the planning and environment field. She has qualifications in Law and Science. She has a family history of liver disease and experience navigating the health system and its complexity as a carer of a person with advanced liver disease.
Ben is the CEO of a Melbourne based community health organisation. He has been a strong advocate for young people, people experiencing homelessness, and the harm reduction movement for over 15 years. He serves on a number of advisory committees and boards in the community sector.
Darren has over 30 years of experience in Public Health in various finance, accounting and senior management roles. Darren brings a passion and enthusiasm for community health and well-being. A Fellow of CPA Australia and a Fellow of the Institute of Public Accountants, he currently works as a consultant.
Daniel is a Victorian public service executive with extensive reform experience across health and human services, emergency management and criminal justice. Holding qualifications in Law and Project Management, he also has a keen interest in community health, particularly within his local municipality, where he serves on advisory committees at Eastern Health.
Jawid has more than ten years experience working in the health sector in Australia and overseas in many areas, including project management, community development, health promotion, monitoring and evaluation, contract and grant management of health services, research, humanitarian aid, and refugee settlement programs.
Siân is a change leader experienced in building global capabilities and high performing teams. Siân originally qualified as a pharmacist in the UK, has an MBA, is a Graduate of the AICD and has recently completed the MPH at University of Melbourne.
Daphne is an experienced executive leader and senior Patient Safety Physician from the pharmaceutical industry with a proven track record of leadership competence and strategic thinking. As a physician and an advocate for patient safety for over 15 years, Daphne has extensive clinical/safety governance expertise, particularly in the domain of risk management strategies relating to patient safety. She is passionate about advancing patient and community health outcomes, wellbeing, and quality of life through partnership with healthcare professionals, regulators, consumers, and the community.
Sharon has held a number of Executive roles in highly regulated and complex, blue-chip organisations. Her breadth of industry experience spans Banking and Finance, Manufacturing and Automotive, Insurance, Building and Construction, Retail and Government, Private Equity and Impact Investment. Sharon translates her executive experience into governance oversight with subject matter expertise in a variety of disciplines including Strategy and Transformation, Business Optimisation, Culture and Change, and large scale complex Operational Leadership.
Associate Professor Paul Gow has spent the last 30 years involved in various aspects of liver health and disease, as a Gastroenterologist and Liver Transplant Specialist at the Austin Hospital and in private practice. With a wealth of clinical experience, Paul cares strongly about liver health education and advocacy and is committed to excellence in patient-centered care. Paul has a particular interest in liver disease (viral hepatitis, fatty liver disease and auto-immune liver diseases).